专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070238683A1 MODIFIED AND STABILIZED GDF PROPEPTIDES AND USES THEREOF 失效
标题翻译：修改和稳定的GDF预测及其用途
公开(公告)号：US20070238683A1
公开(公告)日：2007-10-11
申请号：US11614594
申请日：2006-12-21
申请人： Neil Wolfman , Soo-Peang Khor , Kathleen Tomkinson
发明人： Neil Wolfman , Soo-Peang Khor , Kathleen Tomkinson
IPC分类号： A61K31/7052 , C07H21/04 , C12N15/00 , C12N5/06
CPC分类号： C07K14/475 , C07K14/51 , C07K16/18 , C07K2319/00
摘要： Modified and stabilized propeptides of Growth Differentiation Factor proteins, such as GDF-8 and Bone Morphogenetic Protein-11, are disclosed. Also disclosed are methods for making and using the modified propeptides to prevent or treat human or animal disorders in which an increase in muscle tissue would be therapeutically beneficial. Such disorders include muscle or neuromuscular disorders (such as amyotrophic lateral sclerosis, muscular dystrophy, muscle atrophy, congestive obstructive pulmonary disease, muscle wasting syndrome, sarcopenia, or cachexia), metabolic diseases or disorders (such as such as type 2 diabetes, noninsulin-dependent diabetes mellitus, hyperglycemia, or obesity), adipose tissue disorders (such as obesity), and bone degenerative diseases (such as osteoporosis).
摘要翻译：公开了生长分化因子蛋白如GDF-8和骨形态发生蛋白-11的修饰和稳定的前肽。还公开了制备和使用经修饰的前肽以预防或治疗其中肌肉组织增加在治疗上有益的人或动物疾病的方法。这些疾病包括肌肉或神经肌肉疾病（例如肌萎缩性侧索硬化症，肌营养不良症，肌肉萎缩，充血性阻塞性肺病，肌肉萎缩综合症，肌营养不良或恶病质），代谢疾病或病症（如2型糖尿病，非胰岛素依赖性糖尿病高血糖或肥胖），脂肪组织障碍（如肥胖症）和骨退行性疾病（如骨质疏松症）。

2. 发明申请

US20070149455A1 MODIFIED AND STABILIZED GDF PROPEPTIDES AND USES THEREOF 失效
标题翻译：修改和稳定的GDF预测及其用途
公开(公告)号：US20070149455A1
公开(公告)日：2007-06-28
申请号：US11614702
申请日：2006-12-21
申请人： Neil Wolfman , Soo-Peang Khor , Kathleen Tomkinson
发明人： Neil Wolfman , Soo-Peang Khor , Kathleen Tomkinson
IPC分类号： A61K38/18 , C07K14/475
CPC分类号： C07K14/475 , C07K14/51 , C07K16/18 , C07K2319/00
摘要： Modified and stabilized propeptides of Growth Differentiation Factor proteins, such as GDF-8 and Bone Morphogenetic Protein-11, are disclosed. Also disclosed are methods for making and using the modified propeptides to prevent or treat human or animal disorders in which an increase in muscle tissue would be therapeutically beneficial. Such disorders include muscle or neuromuscular disorders (such as amyotrophic lateral sclerosis, muscular dystrophy, muscle atrophy, congestive obstructive pulmonary disease, muscle wasting syndrome, sarcopenia, or cachexia), metabolic diseases or disorders (such as such as type 2 diabetes, noninsulin-dependent diabetes mellitus, hyperglycemia, or obesity), adipose tissue disorders (such as obesity), and bone degenerative diseases (such as osteoporosis).
摘要翻译：公开了生长分化因子蛋白如GDF-8和骨形态发生蛋白-11的修饰和稳定的前肽。还公开了制备和使用经修饰的前肽以预防或治疗其中肌肉组织增加在治疗上有益的人或动物疾病的方法。这些疾病包括肌肉或神经肌肉疾病（如肌萎缩性侧索硬化，肌营养不良，肌肉萎缩，充血性阻塞性肺疾病，肌肉萎缩综合征，肌营养不良或恶病质），代谢疾病或病症（例如2型糖尿病，依赖性糖尿病，高血糖或肥胖），脂肪组织障碍（如肥胖症）和骨退行性疾病（如骨质疏松症）。

3. 发明申请

US20070161046A1 Truncated aggrecanase molecules 审中-公开
标题翻译：截短的聚蛋白聚糖酶分子
公开(公告)号：US20070161046A1
公开(公告)日：2007-07-12
申请号：US11640482
申请日：2006-12-15
申请人： Katy Georgiadis , Tara Crawford , Kathleen Tomkinson , Lisa Collins-Racie , Christopher Corcoran , Bethany Freeman , Edward LaVallie
发明人： Katy Georgiadis , Tara Crawford , Kathleen Tomkinson , Lisa Collins-Racie , Christopher Corcoran , Bethany Freeman , Edward LaVallie
IPC分类号： G01N33/53 , C07H21/04 , C12P21/06 , C12N9/64 , C07K16/40
CPC分类号： C12N9/6421
摘要： Truncated aggrecanase proteins and nucleotides sequences encoding them as well as processes for producing them are disclosed. Additionally, aggrecanases with amino acid mutations that lead to increased stability and expression levels in comparison with wild-type or native aggrecanases are also disclosed. Aggrecanases of the invention are especially useful for development of compositions for treatment of diseases such as osteoarthritis. Methods for developing inhibitors of the aggrecanase enzymes and antibodies to the enzymes for treatment of conditions characterized by the degradation of aggrecan are also disclosed.
摘要翻译：公开了截短的聚蛋白聚糖蛋白聚糖蛋白和编码它们的核苷酸序列及其生产方法。此外，还公开了与野生型或天然聚集蛋白聚糖蛋白聚糖酶相比导致增加的稳定性和表达水平的氨基酸突变的聚集蛋白聚糖蛋白聚糖酶。本发明的骨灰蛋白酶特别可用于开发用于治疗疾病如骨关节炎的组合物。还公开了开发聚蛋白聚糖酶的抑制剂的方法和用于治疗以聚集蛋白聚糖降解为特征的病症的酶的抗体的方法。

4. 发明申请

US20060257989A1 Truncated aggrecanase molecules 失效
标题翻译：截短的聚蛋白聚糖酶分子
公开(公告)号：US20060257989A1
公开(公告)日：2006-11-16
申请号：US11488340
申请日：2006-07-18
申请人： Katy Georgiadis , Tara Crawford , Kathleen Tomkinson , Lisa Collins-Racie , Christopher Corcoran , Bethany Freeman , Edward LaVallie
发明人： Katy Georgiadis , Tara Crawford , Kathleen Tomkinson , Lisa Collins-Racie , Christopher Corcoran , Bethany Freeman , Edward LaVallie
IPC分类号： C12N9/64 , C07H21/04 , C12P21/06 , C07K16/40
CPC分类号： C12N9/6421
摘要： Truncated aggrecanase proteins and nucleotides sequences encoding them as well as processes for producing them are disclosed. Additionally, aggrecanases with amino acid mutations that lead to increased stability and expression levels in comparison with wild-type or native aggrecanases are also disclosed. Aggrecanases of the invention are especially useful for development of compositions for treatment of diseases such as osteoarthritis. Methods for developing inhibitors of the aggrecanase enzymes and antibodies to the enzymes for treatment of conditions characterized by the degradation of aggrecan are also disclosed.
摘要翻译：公开了截短的聚蛋白聚糖蛋白聚糖蛋白和编码它们的核苷酸序列及其生产方法。此外，还公开了与野生型或天然聚集蛋白聚糖蛋白聚糖酶相比导致增加的稳定性和表达水平的氨基酸突变的聚集蛋白聚糖蛋白聚糖酶。本发明的骨灰蛋白酶特别可用于开发用于治疗疾病如骨关节炎的组合物。还公开了开发聚蛋白聚糖酶的抑制剂的方法和用于治疗以聚集蛋白聚糖降解为特征的病症的酶的抗体的方法。

5. 发明申请

US20050042220A1 Antibodies against interleukin-22 and uses therefor 失效
标题翻译：抗白细胞介素-22抗体的用途
公开(公告)号：US20050042220A1
公开(公告)日：2005-02-24
申请号：US10873972
申请日：2004-06-22
申请人： Jing Li , Xiang-Yang Tan , Kathleen Tomkinson , Debra Pittman , Geertruida Veldman , Lynette Fouser
发明人： Jing Li , Xiang-Yang Tan , Kathleen Tomkinson , Debra Pittman , Geertruida Veldman , Lynette Fouser
IPC分类号： A61K38/20 , C07K14/54 , C07K16/24 , A61K39/395
CPC分类号： C07K16/244 , A61K39/395 , A61K45/06 , A61K2039/505 , C07K14/54 , C07K14/5428 , C07K2317/34 , C07K2317/73 , C07K2317/76 , C12N2799/022 , A61K2300/00
摘要： Antibodies and antigen-binding fragments thereof that bind interleukin-22 (IL-22), in particular, human IL-22, and their uses in regulating IL-22-associated immune responses are disclosed. The antibodies disclosed herein are useful in diagnosing, preventing, or treating IL-22-associated immune disorders, e.g., autoimmune disorders (e.g., arthritis).
摘要翻译：公开了结合白介素22（IL-22），特别是人IL-22的抗体及其抗原结合片段及其在调节IL-22相关免疫应答中的用途。本文公开的抗体可用于诊断，预防或治疗IL-22相关免疫病症，例如自身免疫性疾病（例如关节炎）。

6. 发明授权

US06136536A Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins 有权
标题翻译：快速产生稳定的哺乳动物细胞系，产生高水平的重组蛋白
公开(公告)号：US06136536A
公开(公告)日：2000-10-24
申请号：US175690
申请日：1998-10-20
申请人： Kathleen Tomkinson , Monique Davies , John McCoy
发明人： Kathleen Tomkinson , Monique Davies , John McCoy
IPC分类号： C12N15/09 , C07K14/035 , C07K14/245 , C12N5/10 , C12N15/63 , C12N15/85 , C12P21/02 , C12N15/00 , A61K48/00 , C12Q1/68
CPC分类号： C07K14/005 , C07K14/245 , C12N15/635 , C12N15/85 , C07K2319/00 , C12N2710/16622 , C12N2710/16634 , C12N2800/108 , C12N2830/006 , C12N2830/42 , C12N2840/203
摘要： Disclosed are methods, DNA sequences, vectors and cell lines useful for the rapid generation of stable mammalian cell lines expressing high levels of recombinant proteins.
摘要翻译：公开了可用于快速产生表达高水平重组蛋白质的稳定的哺乳动物细胞系的方法，DNA序列，载体和细胞系。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式